Home Cart 0 Sign in  
X

[ CAS No. 1320266-90-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1320266-90-7
Chemical Structure| 1320266-90-7
Chemical Structure| 1320266-90-7
Structure of 1320266-90-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1320266-90-7 ]

Related Doc. of [ 1320266-90-7 ]

Alternatived Products of [ 1320266-90-7 ]

Product Details of [ 1320266-90-7 ]

CAS No. :1320266-90-7 MDL No. :MFCD20489125
Formula : C9H10ClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :RMPWIGBWIYVTEF-UHFFFAOYSA-N
M.W : 195.65 Pubchem ID :76849759
Synonyms :

Calculated chemistry of [ 1320266-90-7 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.33
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 0.0
Molar Refractivity : 52.58
TPSA : 30.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.43 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.24
Log Po/w (XLOGP3) : 2.9
Log Po/w (WLOGP) : 2.51
Log Po/w (MLOGP) : 1.06
Log Po/w (SILICOS-IT) : 1.97
Consensus Log Po/w : 2.13

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.33
Solubility : 0.0923 mg/ml ; 0.000472 mol/l
Class : Soluble
Log S (Ali) : -3.19
Solubility : 0.125 mg/ml ; 0.000639 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.16
Solubility : 0.137 mg/ml ; 0.000698 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.25

Safety of [ 1320266-90-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H320-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1320266-90-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1320266-90-7 ]
  • Downstream synthetic route of [ 1320266-90-7 ]

[ 1320266-90-7 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 1320266-89-4 ]
  • [ 1320266-90-7 ]
YieldReaction ConditionsOperation in experiment
98% With N,N-dimethyl-formamide; trichlorophosphate In acetonitrile at 55℃; for 0.5 h; POCl3 (0.08 ml, 0.90 mmol) was added to Intermediate I (37 mg, 0.18 mmol) dissolved in 0.78 mL of acetonitrile. A drop of DMF was added and the reaction mixture was stirred at 55 °C for 30 minutes. The reaction mixture was then concentrated in vacuo and the resultant solid was dissolved in 2 M ammonia in methanol followed by concentrating this solution in vacuo. The resultant solid was dissolved in a minimal amount of water and the product was extracted into dichloromethane (4X). The organic layers were combined and washed with saturated NaHC03, (IX), concentrated in vacuo, and dried over Na2S04. Concentration of the solution afforded 33 mg (98percent yield) of Intermediate J. .H-NMR (300 MHz, CDC13) δ 1.46 (d, 6H, J = 6.9 Hz), 3.29-3.38 (m, 1H), 7.33 (d, 1H, J = 4.8 Hz), 7.61 (d, 1H, J= 5.1 Hz), 7.82 (s, 1H). MS (ESI) (M+H)+ 196
Reference: [1] Patent: WO2011/94628, 2011, A1, . Location in patent: Page/Page column 106
[2] Patent: WO2015/74138, 2015, A1, . Location in patent: Page/Page column 38; 39
  • 2
  • [ 771581-15-8 ]
  • [ 1320266-90-7 ]
Reference: [1] Patent: WO2011/94628, 2011, A1,
  • 3
  • [ 89283-32-9 ]
  • [ 1320266-90-7 ]
Reference: [1] Patent: WO2011/94628, 2011, A1,
  • 4
  • [ 867165-55-7 ]
  • [ 1320266-90-7 ]
Reference: [1] Patent: WO2011/94628, 2011, A1,
  • 5
  • [ 1320266-90-7 ]
  • [ 1320266-92-9 ]
YieldReaction ConditionsOperation in experiment
62% With N-iodo-succinimide In N,N-dimethyl-formamide at 60℃; for 3 h; Intermediate J (33 mg, 0.17 mmol) dissolved in 0.18 mL of DMF was added to NIS (39 mg, 0.17 mmol) dissolved in 0.6 mL of DMF. The reaction mixture was heated to 60 °C for 3 h and then cooled to room temperature. The reaction mixture was partitioned between 1 M a2S03 and dichloromethane. The aqueous layer was then extracted with dichloromethane (3X). The organic layers were combined, dried over a2S04 and concentrated in vacuo to afford 34 mg (62percent yield) of pure Intermediate K. .H-NMR (300 MHz, CDC13) δ 1.41 (d, 6H, / = 6.9 Hz), 3.20-3.31 (m, 1H), 7.28 (d, 1H, J= 5.1 Hz), 7.65 (d, 1H, J = 5.1 Hz). MS (ESI) (M+H)+ 322.1.
Reference: [1] Patent: WO2011/94628, 2011, A1, . Location in patent: Page/Page column 107
  • 6
  • [ 1320266-90-7 ]
  • [ 1320266-94-1 ]
Reference: [1] Patent: WO2011/94628, 2011, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 1320266-90-7 ]

Chlorides

Chemical Structure| 936901-72-3

[ 936901-72-3 ]

3-(8-Chloroimidazo[1,5-a]pyrazin-3-yl)cyclobutanone

Similarity: 0.87

Chemical Structure| 56468-23-6

[ 56468-23-6 ]

8-Chloroimidazo[1,5-a]pyrazine

Similarity: 0.84

Chemical Structure| 1320266-92-9

[ 1320266-92-9 ]

8-Chloro-1-iodo-3-isopropylimidazo[1,5-a]pyrazine

Similarity: 0.82

Chemical Structure| 50432-68-3

[ 50432-68-3 ]

4-Chloro-1-methyl-1H-imidazo[4,5-c]pyridine

Similarity: 0.67

Chemical Structure| 85333-43-3

[ 85333-43-3 ]

8-Chloro-2-methylimidazo[1,2-a]pyrazine

Similarity: 0.65

Related Parent Nucleus of
[ 1320266-90-7 ]

Other Aromatic Heterocycles

Chemical Structure| 936901-72-3

[ 936901-72-3 ]

3-(8-Chloroimidazo[1,5-a]pyrazin-3-yl)cyclobutanone

Similarity: 0.87

Chemical Structure| 56468-23-6

[ 56468-23-6 ]

8-Chloroimidazo[1,5-a]pyrazine

Similarity: 0.84

Chemical Structure| 1320266-92-9

[ 1320266-92-9 ]

8-Chloro-1-iodo-3-isopropylimidazo[1,5-a]pyrazine

Similarity: 0.82

Chemical Structure| 50432-68-3

[ 50432-68-3 ]

4-Chloro-1-methyl-1H-imidazo[4,5-c]pyridine

Similarity: 0.67

Chemical Structure| 85333-43-3

[ 85333-43-3 ]

8-Chloro-2-methylimidazo[1,2-a]pyrazine

Similarity: 0.65